Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

Researchers from the Icahn School of Medicine at Mount Sinai have introduced KiNet, an interactive web portal designed to ...

Bayer BAYRY announced the submission of a supplemental new drug application (sNDA) to the FDA for darolutamide. The sNDA is ...

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic ...

The number of new drugs approved each year increased steadily in the first few years of the analysis period, and more than 40 ...

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

Biohaven said its experimental treatment for a rare neurological condition showed "a robust and clinically meaningful" ...

The new drug, Bristol Myers Squibb’s Cobenfy ... In November, the FDA agreed to review Karuna’s application. The next month, ...

Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

The stock hits an intraday high on Thursday, October 3, 2024, after getting approval from USFDA for general medication drug.

The Food and Drug Administration in the US has just approved Cobenfy, which one researcher referred to as a "game changer" ...